Nootropics Index - Save on smarter supplements
Amino acids & derivatives

L-Arginine

L-arginine

L-arginine is a nitric-oxide precursor sold as powders, capsules, tablets, salts, and pre-workout blends. Exercise and nootropic benefits are not reliable, while blood-pressure and erectile-function findings are population-specific. For generally healthy adults using ordinary short-term oral amounts it fits minimal risk: mild GI effects are possible, while low blood pressure, recent heart attack, and combinations with nitrates, blood-pressure drugs, or PDE5 drugs are specific higher-risk contexts.

Physical PerformanceNitric Oxide RelatedBlood Flow SupportFood DerivedWater SolubleBioavailability SensitiveSports Nutrition
Updated July 2026/10 min read/11 citations
Prepared by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

What this L-Arginine page covers

2

This page covers plain L-arginine powders, capsules, and tablets. L-arginine hydrochloride, AAKG, L-citrulline, and multi-ingredient pre-workouts need separate form and active-gram comparison rather than being treated as identical products.

Evidence position2
L-arginine is a nitric-oxide precursor, but a plausible vascular mechanism does not guarantee a workout or nootropic benefit. Exercise evidence is limited and largely negative; blood-pressure and erectile-function findings are more specific to the populations and endpoints studied.
Why the overall tier is minimal3
For generally healthy adults, ordinary short-term oral L-arginine use is very low concern. Randomized-trial safety evidence found no significant overall increase in GI symptoms, and NIH ODS describes up to 9 g/day for several days or weeks as generally well tolerated. Blood-pressure effects, recent-heart-attack history, and specific drug combinations remain important exceptions rather than reasons to raise the baseline tier.
02

Names, aliases and forms

Common NamesL-Arginine; Arginine
AbbreviationL-Arg
Cas Number74-79-3
Pubchem Cid6322
Molecular FormulaC6H14N4O2
Salt FormL-arginine hydrochloride
03

Mechanisms of action

A proteinogenic amino acid

1

L-arginine is the physiologically active L-isomer of arginine and a proteinogenic amino acid. It is present in food and synthesized in the body; its normal biological roles are not proof that extra oral intake improves performance or cognition.

Nitric oxide precursor, not a guaranteed pump

2

Nitric oxide synthase can use L-arginine to produce nitric oxide, which participates in vascular tone. Oral exposure, baseline status, metabolism, and training context all limit how confidently that pathway can be translated into a visible pump, endurance, or recovery outcome.

Oral exposure is limited and variable

4

In ten healthy volunteers, a single oral 10 g dose had approximately 20% absolute bioavailability. This helps explain why gram amounts and chemical form matter, but it is not a reason to increase the dose.

04

Potential effects and evidence map

L-arginine is a well-characterized nitric-oxide substrate, but supplement outcomes depend on endpoint and population. NIH ODS finds little to no consistent exercise benefit. A 2022 meta-analysis found a measurable blood-pressure-lowering effect across randomized trials, and condition-specific meta-analysis suggests possible benefit in mild to moderate erectile dysfunction. These vascular findings do not establish a general nootropic, pump, endurance, libido, or testosterone effect.

Effect domainMagnitudeGrade
Physical energy / endurance2
Acute + cumulativeConfidence: High

Exercise-performance evidence is limited and conflicting, with little to no reliable benefit across many anaerobic and aerobic studies.

Note Keep pump, endurance, strength, and recovery claims weaker than the mechanism.

1/5
C
Libido / vitality7
CumulativeConfidence: Medium

Condition-specific trials suggest possible benefit for mild to moderate erectile dysfunction, but this is not a general libido, vitality, or testosterone effect.

Note Do not convert clinical ED findings into a broad healthy-user claim.

2/5
B
Focus / attention
UnknownConfidence: Medium

Direct focus or attention improvement is not established for L-arginine supplementation in healthy adults.

Note Absence-of-evidence positioning; do not infer cognition from nitric-oxide biology.

0/5
E
05

Typical dosages and timing

Typical
2-9 g/day
Not a recommendation
Daily context22-9 g/day

Use 2-9 g/day as a product-listing comparison range, not a personalized target. NIH ODS reports exercise studies from 2-20 g/day and short-term tolerability up to 9 g/day, while higher study doses should not be normalized into routine use.

Dose-sensitive39-30 g/day

NIH ODS reports that GI discomfort and slight blood-pressure reduction are more common at 9-30 g/day. The healthy-adult safety review estimated a 7.531 g no-observed-adverse-effect level for a single dose; this is a research estimate, not an intake recommendation.

Normalize2active grams

Compare the amount of actual L-arginine, not scoop size, capsule count, or total blend mass. Salt forms and AAKG should not be priced as though every gram were a gram of free-form L-arginine.

06

Timing & effect horizon

Effect horizonAcute + cumulative
AcuteCumulative
Peak4Acute
1 hour
Exercise trial length2Cumulative
1-28 days
Safety evidence window3Cumulative
1-84 days
Post-MI trial6Cumulative
6 months
Oral peak is not effect onset4

A single oral 10 g dose reached peak plasma L-arginine concentration at about one hour in healthy volunteers. This is a blood-level marker, not a reliable time-to-pump, focus, or performance benefit.

Exercise trial length was short2

NIH ODS notes that many athlete studies lasted 1-28 days and still found little to no consistent effect on nitric oxide, blood flow, exercise metabolites, or performance. This is the intervention-duration range in those studies, not a recommended cycle.

Healthy-adult safety evidence is short term3

The 2023 healthy-adult safety review covered randomized trials lasting 1-84 days. This is the duration range represented in the safety evidence, not a suggested course of use, and it does not establish indefinite high-dose safety.

The post-heart-attack signal came from a long trial6

The VINTAGE MI trial used 3 g three times daily for six months after acute myocardial infarction. Its harm signal is a specific recent-heart-attack warning, not evidence that healthy users face the same risk.

07

Safety, side effects and risk profile

Do not use after a recent heart attack without specialist direction6
In VINTAGE MI, six participants receiving L-arginine died versus none receiving placebo, and enrollment was stopped. The trial does not establish risk in healthy adults, but it supports a clear avoid-self-use warning after a recent myocardial infarction.
GI discomfort3
Confidence: High

Mild nausea, abdominal discomfort, bloating, or diarrhea can occur, especially with larger single or daily amounts.

Note The healthy-adult randomized-trial review found no significant overall increase in GI symptoms; keep this as a mild dose-sensitive risk.

1/5
A
Cardiovascular caution5
Confidence: High

L-arginine can lower blood pressure, but this is not usually harmful in healthy adults; low blood pressure, recent myocardial infarction, and vasodilating drug combinations are separate caution contexts.

Note Keep the recent-heart-attack red flag prominent without allowing that vulnerable population to inflate typical healthy-adult risk.

1/5
A
Headache / dizziness8
Confidence: Medium

Headache or lightheadedness is possible, particularly when blood pressure falls or L-arginine is combined with other vasodilating products.

Note Secondary clinical-summary evidence; keep the score mild.

1/5
C
Pregnancy / lactation caution8
Confidence: Low

Pregnancy-specific clinical protocols do not establish general supplement self-use safety, and lactation guidance is insufficient.

Note Treat as a population-specific data and supervision context, not demonstrated harm.

1/5
D
Baseline3Minimal risk

Across 34 double-blind randomized trials in healthy people, oral L-arginine did not significantly increase reported GI symptoms overall. Together with the NIH ODS short-term assessment, this supports minimal overall risk for ordinary use while preserving dose- and person-specific cautions.

Common limiter2

Nausea, abdominal discomfort, bloating, or diarrhea can occur, especially with larger single or daily amounts. These effects are generally mild and reversible but can make high-dose powders impractical.

Vascular effect5

A 22-trial meta-analysis found average reductions in systolic and diastolic blood pressure, with a dose-response signal beginning around 4 g/day for systolic pressure. In otherwise healthy adults this physiological effect is not automatically harmful, but it matters for low baseline blood pressure and blood-pressure-lowering combinations.

Clinical review8

Get individualized review before combining L-arginine with nitrates, blood-pressure drugs, sildenafil or similar PDE5 drugs, anticoagulant or antiplatelet products, glucose-lowering drugs, or potassium-sparing diuretics. Several combinations can compound low blood pressure, bleeding, glucose, or potassium concerns.

Population gap8

Although L-arginine has been studied in pregnancy-specific clinical settings, those protocols do not establish over-the-counter self-use safety or dosing. Pregnancy and lactation use should remain clinician-directed.

Individual caution8

Mayo Clinic notes possible allergic response, airway inflammation, or worsening asthma symptoms. People with relevant histories should not treat a generally low headline tier as proof of individual suitability.

09

How it compares

Salt form8

L-arginine hydrochloride includes hydrochloride salt mass. Compare the label-declared L-arginine amount when available rather than assuming gram-for-gram equivalence with free-form base powder.

Different form2

Arginine alpha-ketoglutarate combines arginine with alpha-ketoglutarate. It belongs in a separate form comparison and should not be counted as plain L-arginine gram for gram.

Different route2

L-citrulline can contribute to arginine metabolism but is a distinct ingredient with separate dosing and evidence. Product cards and price comparisons should not merge the two as synonyms.

10

Practical buying and quality notes

  • Compare powders by price per gram of declared L-arginine after shipping and discounts. For capsules, calculate total active grams per container; for blends, exclude caffeine, creatine, citrulline, flavoring, and proprietary-matrix weight.2
  • Single-ingredient evidence cannot predict a multi-ingredient formula. Check whether the label discloses each active amount and avoid assuming that a nitric-oxide blend has the same evidence or safety profile as plain L-arginine.2
  • Look for a batch-specific certificate of analysis, amino-acid identity and purity testing, microbial and heavy-metal results, and independent sport certification when relevant. Certification supports label confidence but does not prove efficacy.2
11

FAQ

Does L-arginine work as a nootropic?

No reliable human supplementation evidence was identified for direct focus, memory, or mental-performance improvement in healthy adults. Nitric-oxide biology is not enough to establish a nootropic effect.

Does L-arginine improve workout performance?

2

NIH ODS summarizes the evidence as limited and conflicting, with little to no effect across many anaerobic and aerobic studies. A pump mechanism should not be presented as reliable strength, endurance, or recovery benefit.

What dose should product listings make easy to compare?

2

A 2-9 g/day range is useful for comparing labels and short-term safety context, not for choosing a personal dose. Larger trial amounts can produce more GI discomfort and blood-pressure change.

Can L-arginine lower blood pressure?

5

Yes, randomized-trial meta-analysis shows a measurable average lowering effect. That does not make an over-the-counter product a treatment, and it is the main reason low blood pressure and blood-pressure-lowering combinations require caution.

Who should avoid self-use?

6

People with a recent heart attack should not self-use L-arginine. Clinical review is also important with low blood pressure, cardiovascular disease, the drug combinations listed above, pregnancy or lactation, and asthma or serious allergy history.

Is L-arginine the same as AAKG or L-citrulline?

2

No. AAKG is a combination form and L-citrulline is a different amino acid. Compare active mass, evidence, and safety separately rather than treating the names as interchangeable.

Is L-arginine safe?

3

For generally healthy adults using ordinary short-term oral amounts, L-arginine fits a minimal-risk profile. Mild GI effects remain possible, while the important recent-heart-attack and drug-combination warnings apply to specific higher-risk contexts rather than the baseline user.

12

References

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 6322, L-Arginine.
  2. NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals.
  3. Kuramochi Y, Murata M, Sumino A, Sone H, Hayamizu K. Safety assessment of L-Arg oral intake in healthy subjects: a systematic review of randomized control trials. Amino Acids. 2023;55(12):1949-1964.
  4. Tangphao O, Grossmann M, Chalon S, Hoffman BB, Blaschke TF. Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. Br J Clin Pharmacol. 1999;47(3):261-266.
  5. Shiraseb F, Asbaghi O, Bagheri R, et al. Effect of L-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials. Adv Nutr. 2022;13(4):1226-1242.
  6. Schulman SP, Becker LC, Kass DA, et al. L-arginine therapy in acute myocardial infarction: the VINTAGE MI randomized clinical trial. JAMA. 2006;295(1):58-64.
  7. Rhim HC, Kim MS, Park YJ, et al. The Potential Role of Arginine Supplements on Erectile Dysfunction: A Systematic Review and Meta-Analysis. J Sex Med. 2019;16(2):223-234.
  8. Mayo Clinic. L-arginine.
  9. U.S. Food and Drug Administration. Structure/Function Claims.
  10. EFSA NDA Panel. Scientific Opinion on the substantiation of health claims related to L-arginine. EFSA Journal. 2011;9(4):2051.
  11. European Commission. EU Register of Health Claims.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.